NCT04221360View on ClinicalTrials.gov

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375

PHASE1UnknownINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

March 6, 2020

Study Completion Date

June 8, 2020

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

CKD-375

Test drug, QD, PO

DRUG

D390

Reference drug, QD, PO

Trial Locations (1)

Unknown

Yonsei University Severance Hospital, Soeul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT04221360 - A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375 | Biotech Hunter | Biotech Hunter